Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360294A2 Regulation of human dorsal root receptor-like g protein-coupled receptor
11/12/2003EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
11/12/2003EP1360292A2 Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof
11/12/2003EP1360291A2 Human polynucleotides and polypeptides encoded thereby
11/12/2003EP1360290A2 Co-stimulatory molecules
11/12/2003EP1360282A2 Degradation and detection of tse infectivity
11/12/2003EP1360206A2 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof
11/12/2003EP1360204A2 Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis
11/12/2003EP1360203A1 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
11/12/2003EP1360202A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
11/12/2003EP1360201A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity
11/12/2003EP1360200A2 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity
11/12/2003EP1360198A2 Novel polypeptides and nucleic acids encoded thereby
11/12/2003EP1360197A2 Histidine phosphatase interacting protein with 240kd
11/12/2003EP1360195A2 H. influenzae antigen basb213
11/12/2003EP1360194A2 Systems for expression of heterologous proteins in m. capsulatus
11/12/2003EP1360193A1 Method for purifying the helicobacter adhesin-like protein a (alpa)
11/12/2003EP1359941A2 Albumin-based drug delivery system and antimicrobial peptides
11/12/2003EP1359938A2 Method for treating psoriasis by using an il-17d antagonist
11/12/2003EP1359932A2 Tip39 polypeptides
11/12/2003EP1359904A2 P27 prevents cellular migration
11/12/2003EP1196637A4 Peptide acceptor ligation methods
11/12/2003EP1117677B1 Ligand presenting assembly (lpa), method of preparation and uses thereof
11/12/2003EP1051187B1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
11/12/2003EP0994904B1 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
11/12/2003EP0938574B1 Method for inducing viral resistance into a plant
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003EP0886648B1 Compounds and peptides that bind to the erythropoietin receptor
11/12/2003EP0882067B1 Methods of treating vascular disease with tnf antagonists
11/12/2003EP0840742A4 Systematic evolution of ligands by exponential enrichment: chemi-selex
11/12/2003EP0775203B1 Method of gene therapy using dna vectors without selection marker gene
11/12/2003EP0773952B1 Interaction trap systems for detecting protein interactions
11/12/2003EP0759759B1 P75 tnf receptor promoters
11/12/2003EP0752883B1 Use of mcp-1 for inducing ripening of the cervix
11/12/2003EP0742829B1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/12/2003EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications
11/12/2003CN1455866A Detection of infectious agents using antigen mmics
11/12/2003CN1455816A Rescue of canine distemper virus from CDNA
11/12/2003CN1455815A Malaria plasmodium antigen polypeptide SE36, method of purifying same and vaccine and diagnosis with use of obtained antigen
11/12/2003CN1455781A Discrimination between GnRH-Ôàáand GnRH-Ôàí"
11/12/2003CN1455687A Hydrophobic muticomponent heparin conjugates, preparing method and use thereof
11/12/2003CN1455682A Compositions for gene therapy of rheumatoid arthritis including gene encoding anti-angiogenic protein or parts thereof
11/12/2003CN1455680A MUCl extracellular domain and cancer treatment compositions and methods derived therefrom
11/12/2003CN1455668A Gene conferring resistance to antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same and applications thereof
11/12/2003CN1454997A Rape sodium-hydrogen pump transport protein coding sequence and application thereof
11/12/2003CN1127569C Method for mass production of antimicrobial peptide
11/12/2003CN1127568C Fibroblast growth factor homologs
11/12/2003CN1127518C Preparation of recombinant factor  in protein free medium
11/12/2003CN1127517C Trophic fuctors for central nervous system
11/12/2003CN1127516C Novel polypeptides
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/12/2003CN1127351C Method for inducing antigen-specific T cell tolerance
11/11/2003USRE38313 4 immunoglobulin type extracellular domains having arginine residues substituted by glutamic acid; immunosuppressants; preventing specific binding to major histocompatibility complex
11/11/2003US6646243 Fixing biopolymers to substrate; obtain substrate, incubate with nucleotide sequences, expose to activator, recover product
11/11/2003US6646183 DNA encoding for a disease resistance gene from common bean and methods of use
11/11/2003US6646182 Mre11 orthologue and uses thereof
11/11/2003US6646116 Variant tax gene of bovine leukemia virus
11/11/2003US6646115 Identification of transcription factor within a cAMP-responsive transcriptional enhancer binding protein (CREB), and uses therefore
11/11/2003US6646113 Nucleic acid molecule encoding human survival of motor neuron-interacting protein 1 (SIP1) deletion mutants
11/11/2003US6646110 G-CSF polypeptides and conjugates
11/11/2003US6646109 Antibody that binds specifically; blocked by nicotine
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645934 Peptide with radio protective effect
11/11/2003US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes
11/11/2003US6645775 Insulin-like growth factor agonist molecules
11/11/2003US6645761 Use to enhance the expression of the encoded polypeptide in mammalian cells
11/11/2003US6645760 Negative strand RNA viral vector having autonomous replication capability
11/11/2003US6645755 Vector modified by sequence coding for a sequence of amino acids contained in a mammalian protein having the biological activity of a membrane receptor, expression of this sequence in transformed unicellular cultures by means of this vector, procedure for studying ligands recognizing these receptors
11/11/2003US6645748 Mitosis; kinetochores; immunoassay; spindle; kits; Xenopus; use to demonstrate Centromere-Associated Protein-E (CENP-E) role in mitosis and identify modulators of CENP-E activity for therapeutic, diagnostic or bioagricultural applications
11/11/2003US6645740 Nucleic acids encodings equine GM-CSF
11/11/2003US6645739 Genetic engineering; for production of enzymes, growth factors, cytokines, immunogenic proteins, and immunoglobulin proteins
11/11/2003US6645738 DNA molecules encoding the melanocortin 5 receptor protein from rhesus monkey
11/11/2003US6645726 Canine growth hormone secretagogue receptor
11/11/2003US6645724 Relating to recombinant Factor C (rFC) of a horseshoe crab as produced in an insect cell system; use as a "next generation" limulus amoebocyte lysate (LAL) in the detection and removal of endotoxins
11/11/2003US6645509 Treating the thinning of the epidermis with said polypeptide
11/11/2003US6645504 Certain antigens (called "bystander antigens" and defined below) causes T-cells to be elicited that in turn suppress cells that contribute to immune attack of the organ or tissue involved in an autoimmune disease
11/11/2003US6645501 Anti-pathogen system and methods of use thereof
11/11/2003US6645500 Method for down-regulating osteoprotegerin ligand activity
11/11/2003US6645499 Human ena/VASP-like protein splice variant
11/11/2003US6645498 Soluble variants of type I membrane proteins, and methods of using them
11/11/2003US6645497 Polynucleotide compositions encoding broad-spectrum δ endotoxins
11/11/2003US6645496 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion by administering Botulinum toxin type A
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003US6645493 Composition containing anti-MIF antibody
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003US6645490 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003CA2340070C Non-virulent porphyromonas gingivalis mutant
11/11/2003CA2259594C Subunit respiratory syncytial virus vaccine preparation
11/11/2003CA2210294C Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
11/11/2003CA2132344C Super porous polysaccharide gels
11/11/2003CA2092097C Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
11/11/2003CA2056279C Cell-free receptor binding assays, the production and use thereof
11/07/2003CA2385194A1 Method of diagnosis and treatment for affective disorders
11/06/2003WO2003091698A2 Cetp genetic markers for statin-specific changes in hdl cholesterol
11/06/2003WO2003091690A2 Cancer-associated nucleic acids and polypeptides
11/06/2003WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003WO2003091451A1 Diagnostic and therapeutic use of ensadin-0138 gene and protein for neurodegenerative diseases
11/06/2003WO2003091448A2 696803, a human transporter family member and uses therefor